A large animal noninjury model for study of human stem cell plasticity
- PMID: 14757417
- DOI: 10.1016/j.bcmd.2003.09.018
A large animal noninjury model for study of human stem cell plasticity
Abstract
In this paper, we describe an experimental model that allows evaluation of the full potential of stem cells under normal physiological conditions and in the absence of genetic or injury-induced dysfunction, thus serving as a valuable tool for the study of the mechanism(s) underlying stem cell differentiation. The fetal sheep model of human stem cell transplantation permits the robust formation of donor-derived tissue-specific cells in the absence of selective pressure given its unique characteristics: the preimmune status of the fetus allows donor stem cell engraftment without significant rejection and the existence of the naturally occurring migratory patterns in the fetus facilitates the widespread efficient distribution of donor stem cells throughout the body. The cells are then influenced by the stimulatory environment of the specific tissue or organ to undergo proliferation and directed differentiation. The versatility of this noninjury fetal model of human stem cell plasticity was demonstrated by revealing the differentiative potential of different populations of both human hematopoietic stem cells and human mesenchymal stem cells (MSC).
Similar articles
-
Plasticity of human stem cells in the fetal sheep model of human stem cell transplantation.Int J Hematol. 2004 Jan;79(1):1-6. doi: 10.1007/BF02983526. Int J Hematol. 2004. PMID: 14979471 Review.
-
The fetal sheep: a unique model system for assessing the full differentiative potential of human stem cells.Yonsei Med J. 2004 Jun 30;45 Suppl:7-14. doi: 10.3349/ymj.2004.45.Suppl.7. Yonsei Med J. 2004. PMID: 15250043 Review.
-
Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep.Blood Cells Mol Dis. 2001 May-Jun;27(3):601-4. doi: 10.1006/bcmd.2001.0424. Blood Cells Mol Dis. 2001. PMID: 11482873
-
Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.Exp Hematol. 2002 Aug;30(8):870-8. doi: 10.1016/s0301-472x(02)00820-2. Exp Hematol. 2002. PMID: 12160838
-
Differentiative potential of human metanephric mesenchymal cells.Exp Hematol. 2002 Dec;30(12):1454-62. doi: 10.1016/s0301-472x(02)00967-0. Exp Hematol. 2002. PMID: 12482508
Cited by
-
Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.Adv Drug Deliv Rev. 2010 Sep 30;62(12):1156-66. doi: 10.1016/j.addr.2010.08.010. Epub 2010 Sep 7. Adv Drug Deliv Rev. 2010. PMID: 20828588 Free PMC article. Review.
-
Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC.Exp Hematol. 2011 Dec;39(12):1124-1135.e4. doi: 10.1016/j.exphem.2011.09.001. Epub 2011 Sep 8. Exp Hematol. 2011. PMID: 21906573 Free PMC article.
-
Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells.Blood Adv. 2018 Jan 5;2(1):69-74. doi: 10.1182/bloodadvances.2017011585. eCollection 2018 Jan 9. Blood Adv. 2018. PMID: 29344586 Free PMC article.
-
Concepts for the clinical use of stem cells in equine medicine.Can Vet J. 2008 Oct;49(10):1009-17. Can Vet J. 2008. PMID: 19119371 Free PMC article. Review.
-
The hematopoietic system in the context of regenerative medicine.Methods. 2016 Apr 15;99:44-61. doi: 10.1016/j.ymeth.2015.08.015. Epub 2015 Aug 28. Methods. 2016. PMID: 26319943 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical